OBI Medical
OBI Medical receives DKK 2.1 million in public funding from the Market Development Fund
25-08-2015

OBI Medical is pleased to announce that the company has received DKK 2.1 million in public funding from Markedsmodningsfonden (in English ’The Market Development Fund’) to support the roll-out of the v-TAC solution into various clinical applications, including NIV treatment and adjustment of oxygen therapy of COPD patients, and screening of acute ill patients in emergency/acute departments. Throughout the project, OBI Medical will work closely with hospitals to collect experiences and ensure a seamless and efficient commissioning and daily use of the solution.

Read the full announcement from Markedsmodningsfonden here:

http://markedsmodningsfonden.dk/projekt/0/34/1432